NOVELTY – The method involves migrating some protein fractions for the superior phase and other remains in the inferior phase. The superior phase and inferior phase has a protein system of separation, once divided a complex protein system in two great fractions. USE – For plasma protein of human blood. ADVANTAGE – The superior phase and inferior phase has a protein system of separation, once divided a complex protein system in two great fractions, and hence cost effective manufacturing of the marker.

Main Application Field

B04 (Natural products and polymers. Including testing of body fluids (other than blood typing or cell counting), pharmaceuticals or veterinary compounds of unknown structure, testing of microorganisms for pathogenicity, testing of chemicals for mutagenicity or human toxicity and fermentative production of DNA or RNA. General compositions.); S03 (Scientific Instrumentation)

INVENTORS:

ARRUDA MARCO AURELIO ZEZZI
LOPES ALINE SORIANO

195_PLASMA

Patent number: BR200501967-A

PATENT STATUS:

For information contact Inova Unicamp

FOR ADDITIONAL INFORMATION:

parcerias@inova.unicamp.br

+55 (19) 3521-5207 / 2607

This technology profile has been automatically generated.